---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-092728"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:57:11.667245+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical Q2 net sales $99.0M (record), EPS $0.15, raises FY2024 guidance

## Summary
- Record Q2 net sales of $99.0M (up 7% YoY); constant currency $100.4M (+9%).
- Net income $7.4M ($0.15 diluted EPS) vs $6.1M ($0.12) YoY; Adjusted EBITDA $22.5M ($0.45).
- Gross margin improved to 79.2% from 76.6% YoY, helped by cataract IOL reserve changes.
- U.S. ICL sales $5.5M (+25% YoY, +10% sequentially); China ICL sales +3% YoY.
- FY2024 net sales guidance raised to $340M-$345M (from $335M-$340M); Adjusted EBITDA ~$42M.

## SEC filing metadata
- accession: 0000950170-24-092728
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000095017024092728/0000950170-24-092728-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000095017024092728/staa-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-092728
- JSON: https://secwatch.observer/filing/0000950170-24-092728.json
- Plain text: https://secwatch.observer/filing/0000950170-24-092728.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.